Development
Cresco Labs Inc.
CL
CNSX
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 756.06M | 766.85M | 786.35M | 805.94M | 824.93M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 756.06M | 766.85M | 786.35M | 805.94M | 824.93M |
| Cost of Revenue | 393.69M | 410.55M | 424.98M | 419.08M | 417.77M |
| Gross Profit | 362.37M | 356.30M | 361.37M | 386.86M | 407.16M |
| SG&A Expenses | 259.43M | 283.67M | 295.49M | 306.15M | 309.35M |
| Depreciation & Amortization | 24.54M | 20.58M | 19.05M | 20.36M | 20.64M |
| Other Operating Expenses | 14.83M | 17.75M | 17.75M | 17.75M | 17.75M |
| Total Operating Expenses | 692.48M | 732.55M | 757.27M | 763.33M | 765.51M |
| Operating Income | 63.57M | 34.31M | 29.08M | 42.61M | 59.42M |
| Income Before Tax | -146.90M | -316.58M | -181.91M | -137.04M | -126.91M |
| Income Tax Expenses | 32.95M | 48.76M | 73.24M | 82.94M | 88.94M |
| Earnings from Continuing Operations | -179.85 | -365.34 | -255.15 | -219.98 | -215.84 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 4.33M | 25.85M | 21.44M | 9.26M | 3.80M |
| Net Income | -175.52M | -339.49M | -233.71M | -210.72M | -212.05M |
| EBIT | 63.57M | 34.31M | 29.08M | 42.61M | 59.42M |
| EBITDA | 126.09M | 91.03M | 83.90M | 95.44M | 111.35M |
| EPS Basic | -0.54 | -1.08 | -0.77 | -0.70 | -0.71 |
| Normalized Basic EPS | 0.02 | 0.03 | 0.00 | 0.01 | 0.02 |
| EPS Diluted | -0.54 | -1.08 | -0.77 | -0.70 | -0.71 |
| Normalized Diluted EPS | 0.02 | 0.03 | 0.00 | 0.01 | 0.02 |
| Average Basic Shares Outstanding | 1.29B | 1.26B | 1.22B | 1.20B | 1.19B |
| Average Diluted Shares Outstanding | 1.29B | 1.26B | 1.22B | 1.20B | 1.19B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |